(Q47248773)
Statements
Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent (English)
Muus P
Donnelly P
Schattenberg A
Linssen P
Minderman H
Dompeling E
1 December 1993